Teva Pharmaceuticals Industries Ltd., Pfizer Inc. and Sanofi are Dominating in the Global Active Pharmaceutical Ingredients (API) Market in 2020

Global Active Pharmaceutical Ingredients (API) Market is expected to grow with the CAGR of 7.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-active-pharmaceutical-ingredient-api-market

Global active pharmaceutical ingredients (API) market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.    

The major players dealing in global active pharmaceutical ingredients (API) market are introducing strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition and agreement into the market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in May 2019, Pfizer Inc. expanded its business by opening of new manufacturing facility in Andover, Massachusetts. The company has adopted this initiative in order to boost up the manufacturing of pharmaceutical products with an aim to improve patient’s treatment options. This initiative allowed the company to build up the strong partnership with the research and development manufacturing teams.

Teva Pharmaceuticals Industries Ltd. is the dominating player in global active pharmaceutical ingredients (API) market. The other key players existing in the active pharmaceutical ingredients (API) market are Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Sanofi, GlaxoSmithKline plc, AARTI INDUSTRIES LIMITED, Recipharm AB, Jubilant Pharmova Limited, LUPIN, Aurobindo Pharma, Alembic Pharmaceuticals Limited, AbbVie Inc., AstraZeneca, Alkem Labs, Albemarle Corporation, Saneca Pharmaceuticals, Unichem Laboratories, Neuland Laboratories Ltd., Divi's Laboratories Limited, HIKAL Ltd., Viatris Inc., Merck KGaA, Novo Nordisk A/S, Sandoz International GmbH (a subsidiary of Novartis AG), Minakem, BASF SE, Cipla Inc., CordenPharma International, Piramal Pharma Solutions among others.

Active Pharmaceutical Ingredients (API) Market

Teva Pharmaceuticals Industries Ltd.:

Teva Pharmaceuticals Industries Ltd. is headquartered in Jerusalem, Israel and was established in 1901. The company is focused on providing the generics and biopharmaceuticals products that will be beneficial for the patient’s life. The company provides wide range of products under categories such as generic medicines, specialty therapeutics areas, biopharmaceuticals, research & development, active pharmaceutical ingredients, producing quality products that improve lives and over the counter (OTC) treatments among which active pharmaceutical ingredients is the market focused category.

For instance,

  • In November 2020, Teva Pharmaceuticals Industries Ltd. had received EcoVadis Silver Medal. The company was awarded due to their best responsibilities regarding environment, labor and human rights practices, ethics and sustainable procurement. EcoVadis award is given to the company according to the company’s global supply chain rating. This award helped the company to get recognized through their supply chains of their products.

The company has presence across Europe, Americas, Asia-Pacific and Middle East and Africa. The company has subsidiaries such as Pliva (Croatia), Ratiopharm (Germany), Cephalon, Inc. (U.S.), Teva Canada (Canada), Mepha (Switzerland) among others.

Pfizer Inc.:

Pfizer Inc. is headquartered in New York, U.S. and was founded in 1849. The company is focused on providing standard for quality, safety and value in the discovery, development and manufacturing of health care products including innovative medicines and vaccines. The company deals in multiple business segments such as Biopharma, upjohn and consumer healthcare out of which biopharma is the market focused segment. The company provides wide range of products under categories such as internal medicine, inflammation & immunology, oncology, rare disease, vaccines and anti infectives among which internal medicine is the market focused category.

 For instance,

  • In 2019, Pfizer Inc. acquired Array BioPharma Inc., a company focused on the discovery, development and commercialization of variety of medicines indicated for treatment of several kinds of diseases. This acquisition allowed the company to accelerate the research and development activities with involvement of company’s pipeline product portfolio. This acquisition has helped the company to boost up the product portfolio and to earn a lucrative growth across several markets including active pharmaceutical ingredients (API) treatment market among others.

The company has presence across Europe, Middle East and Africa, Americas and Asia-Pacific. The company has subsidiaries such as Pfizer Animal Health B.V. (Netherlands), Pfizer Asia International B.V. (Netherlands), Pfizer Australia Superannuation Pty Ltd (Australia), Pfizer Dominicana, S.A. (Dominican Republic), Pfizer Egypt S.A.E. (Egypt) among others.

Sanofi:

Sanofi is headquartered in Paris, France. The company is focused on protecting, enabling and supporting people facing health challenges so that they can live life with their whole potential. The company deals in multiple business segments such as pharmaceuticals, consumer healthcare and vaccines. The company provides wide range of products under categories such as health and well being, diabetes and cardiovascular diseases, oncology, immunology, multiple sclerosis, rare diseases, rare blood disorders, vaccines and active pharmaceutical ingredients among which active pharmaceutical ingredients is the market focused category. 

For instance,

  • In January 2021, Sanofi had announced the name of the European company, EUROAPI that will manufacture as well as commercialize the active pharmaceutical ingredients. This company will be considered as one of the largest API production in Europe. The APIs will be marketed in Europe as well as in other parts of the regions. This has helped the company to expand their business worldwide in the terms of active pharmaceutical ingredients which will increase their market revenues in coming future.

The company has presence across Americas, Europe, Middle East and Africa and Asia-Pacific. The company has subsidiaries such as Sanofi Medley Farmacêutica Ltda. (Medley) (Brazil), Genzyme Europe B.V. (Netherlands), Bioverativ USA Inc. (U.S.), Sanofi-Aventis U.S. LLC (U.S.), sanofi-aventis Canada Inc. (Canada) among others.